Mereo BioPharma Group plc (MREO)

Mereo BioPharma Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	556	297	88	174	243	47
Market Cap Growth	427.60%	238.70%	-49.65%	-28.15%	419.63%	-
Enterprise Value	489	246	35	77	236	67
PE Ratio	-	-10.09	-2.08	10.95	-1.19	-1.07
PS Ratio	-	29.72	-	3.82	-	-
PB Ratio	9.82	5.88	1.71	1.58	-12.96	0.93
P/FCF Ratio	-	-14.06	-1.80	-24.14	-6.84	-0.81
P/OCF Ratio	-	-14.06	-1.80	-26.61	-6.85	-0.81
EV/Sales Ratio	-	24.57	-	1.70	-	-
EV/EBITDA Ratio	-	-8.99	-0.88	3.27	-1.19	-1.52
EV/EBIT Ratio	-	-8.65	-0.86	3.39	-1.18	-1.45
EV/FCF Ratio	-	-11.63	-0.72	-10.71	-6.65	-1.16
Debt / Equity Ratio	0.14	0.12	0.30	0.19	-1.20	0.81
Debt / EBITDA Ratio	-	-0.22	-0.39	0.89	-0.11	-0.92
Debt / FCF Ratio	-	-0.28	-0.31	-2.90	-0.63	-0.71
Quick Ratio	4.42	6.05	2.80	7.63	2.86	0.57
Current Ratio	4.86	6.72	3.09	7.92	3.47	1.02
Asset Turnover	-	0.14	0	0.39	0	0
Interest Coverage	-	-9.86	-9.70	4.54	-25.08	-8.41
Return on Equity (ROE)	-	-57.80%	-52.30%	34.80%	-1294.30%	-95.40%
Return on Assets (ROA)	-	-41.00%	-35.90%	13.40%	-219.10%	-45.30%
Return on Capital (ROIC)	-	-50.30%	-81.51%	-17.76%	-1633.76%	-54.38%
Earnings Yield	-9.92%	-48.12%	9.13%	-84.34%	-93.32%
FCF Yield	-7.11%	-55.66%	-4.14%	-14.62%	-123.07%
Buyback Yield / Dilution	-16.09%	-9.33%	-10.78%	-60.76%	-376.09%	18.21%
Total Shareholder Return	-16.09%	-9.33%	-10.78%	-60.76%	-376.09%	18.21%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).